Leaflet ROMLA 25mg / 25mg / g cream

Product code:
W67556001
Quantity:
1
Indicated for:
local anesthesia
Route of administration:
cutaneous
Substance:
lidocaine + prilocaine (local anesthetics)
ATC
N01BB20 — Nervous system | Anesthetics | Anesthetics, local | Amides
The combination of lidocaine and prilocaine is used for local anesthesia of the skin before medical procedures such as needle insertion or minor surgical interventions. Both substances are local anesthetics that reduce pain sensitivity.

The medication is applied topically, usually in the form of a cream, and should be left to act for 30-60 minutes before the procedure. It is important to follow the doctor's instructions for use.

Side effects may include redness, irritation, or a burning sensation at the application site. In rare cases, allergic reactions or methemoglobinemia may occur.

This combination is not recommended for patients with hypersensitivity to lidocaine, prilocaine, or other components of the product. It should also be used with caution in infants and patients with glucose-6-phosphate dehydrogenase deficiency.

General data about ROMLA 25mg / 25mg / g

Substance:
lidocaine + prilocaine
Date of latest medicines list:
01-05-2021
Product code:
W67556001
Concentration:
25mg / 25mg / g
Pharmaceutical form:
cream
Quantity:
1
Product type:
Generic medicine
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
RAFARM SA - GRECIA
Holder:
MAGNAPHARM MARKETING & SALES ROMANIA S.R.L. - ROMANIA
Number:
13998/2021/01
Shelf life:
3 years-dupa ambalarea pt. coemrcializare;after the first opening-it is used immediately

Pharmaceutical forms available for lidocaine + prilocaine

Concentrations available for lidocaine + prilocaine

  • 150mg/50mg/ml
  • 25mg/25mg/g